ObjectiveHealth
Franklin, US · 164 employees on LinkedIn · 3 known investors
ObjectiveHealth brings clinical trials into local physician practices by integrating technology with electronic health records to identify and match patients to relevant studies. It serves physicians, community health centers, patients, and pharmaceutical sponsors seeking tech-enabled clinical research collaborations.
Also known as Objective Health · ObjectiveGI
Investors · 3
Company profile
researched Aug 2026ObjectiveHealth is an integrated clinical research and technology services provider based in Franklin, Tennessee that brings clinical trials into local physician practices so patients can join studies within their existing care setting. The company supplies research infrastructure, trial selection, study implementation and trained on-site research personnel to partner practices and healthcare organizations, establishing what it originally described as "Center of Research Excellence" partnerships. Its technology integrates directly with electronic health records to identify patients who may benefit from a trial and match them to appropriate studies, and it operates a research data platform combining a clinical trial management system with electronic source data.
The company serves four stated constituencies: pharmaceutical sponsors, physicians, community health centers and patients. Under its earlier ObjectiveGI identity its scientific focus was gastrointestinal disease, particularly nonalcoholic steatohepatitis (NASH), fatty liver disease, metabolic syndrome and next-generation diagnostics. Current focus areas listed by the company are gastroenterology, dermatology, urology, oncology biomarker work and metabolism disorders.
Founding story
The company was founded by a gastroenterologist and a research executive: Dr. Don Lazas, MD, co-founder and chief medical officer, and Colleen Hoke, co-founder and chief executive officer. It began as ObjectiveGI with an initial focus on nonalcoholic steatohepatitis (NASH).
Business model
ObjectiveHealth partners with physician groups, community health centers and healthcare organizations to add clinical research as an ancillary service line within routine care, while offering pharmaceutical sponsors a nationwide, technology-enabled network for running trials. It provides partner sites with research infrastructure, trial selection, study implementation and on-site research staff.
Traction
The company reports 3x more patients enrolled per site per month, screening technology that triages more than 60,000 at-risk patients daily, a 92% retention rate on multiyear trials and more than 22,000 hours of patient care provided to partners annually. Partnered program counts grew from approaching 20 programs across 13 states and over 240 providers in 2021 to figures reported later of close to 25 programs across 16 states with over 400 providers and approaching 31 programs across 16 states with over 600 providers.
Latest developments
A funding database entry records an initial filing in October 2025 reporting $47.2 million raised. The company's current leadership team is led by CEO Steve Clemons, with Jimmy Porter as CFO, Sonny Terrill as chief people officer, Van Johnson as chief commercial officer, Josh O'Rourke as CTO and Charlie Jordan as COO.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Describes itself as an integrated research provider operating at the point of care, working with community practices and health systems rather than dedicated trial sites.
Positions its model on embedding research inside existing patient care workflows to avoid healthcare workflow disruption, combined with EHR-integrated patient identification and on-site research personnel.
Technology
Proprietary software integrates with electronic health records to triage at-risk patients and match them to studies. The research data platform combines a traditional clinical trial management system (CTMS) with an eSource model that accepts multiple data formats and converts them into reporting and analytics; the CTMS/eSource/eRegulatory infrastructure is supplied through a collaboration with Clinical Research IO (CRIO), with mobile access for investigators and cloud security review, penetration testing and redundancy.
Go-to-market
The company builds partnered research programs with community-based physician practices and health systems across multiple US states, and markets research collaborations to pharmaceutical sponsors; a leadership team including a chief commercial officer supports business development.
Pharmaceutical sponsors, physicians and physician practices, community health centers, and patients seeking access to clinical trials.
Geography
Headquartered in Franklin, Tennessee, with earlier press issued from Nashville, Tennessee. Partnered research programs span 13 states as of 2021 and 16 states in later reporting, with sponsor collaborations described as nationwide.
History
Operating as ObjectiveGI, the company announced a collaboration with Clinical Research IO in July 2019 to deliver a combined CTMS and electronic source data platform to partner physician groups. BIP Ventures lists a 2021 partnership date with the company. In September 2021, following a year the company described as one of rapid growth and expanded market demand, ObjectiveGI rebranded as ObjectiveHealth to reflect a broader, provider-focused approach beyond gastroenterology. Leadership subsequently changed, with Steve Clemons serving as chief executive officer.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsA funding tracker reported an initial filing dated October 8, 2025 in which Objective Health disclosed $47.2 million raised, categorized as a venture round of undisclosed series.
$47.2M source ↗
ObjectiveGI announced a new brand identity and name change to ObjectiveHealth, reflecting a broader provider-focused approach and expansion beyond gastrointestinal disease into new research areas.
ObjectiveGI announced an all-inclusive clinical research data management platform for partner physician groups, combining a traditional CTMS with complete electronic source data using CRIO's eSource, eRegulatory and CTMS infrastructure.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- ObjectiveHealthobjectivegi.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does ObjectiveHealth do?
- ObjectiveHealth embeds clinical trials into community physician practices using EHR-integrated technology to find and match patients.
- Who are ObjectiveHealth's investors?
- ObjectiveHealth's investors include BIP Ventures, Frist Cressey Ventures, Vitruvian Partners.
- Where is ObjectiveHealth headquartered?
- ObjectiveHealth is headquartered in Franklin, US.